Literature DB >> 367136

Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.

J E Markis, R Gorlin, R M Mills, R A Williams, P Schweitzer, B J Ransil.   

Abstract

The efficacy of oral isosorbide dinitrate was evaluated in nine hospitalized patients with chronic angina pectoris and positive maximal bicycle exercise tests. Patients were randomized double-blind to receive either 20 mg of isosorbide dinitrate or placebo on successive days after a control maximal upright bicycle exercise test. On each day hourly exercise tests were performed for 4 hours after drug administration to an end point of fatigue or angina pectoris. Mean systolic blood pressure 4 hours after the administration of isosorbide dinitrate was 25 mm Hg less than the control value (P less than 0.001). The values for resting heart rate and exercise-attained heart rate-blood pressure product were not significantly different from the values after placebo. The duration of exercise was prolonged (P less than 0.025) for at least 3 hours, and less ST depression (P less than 0.01) was observed up to 3 hours after the administration of isosorbide dinitrate compared with control values. The demonstration of sustained imporved exercise performance and previously described hemodynamic effects with the use of higher doses suggests that adequate blood levels of isosorbide dinitrate or mononitrate metabolites may be important for the efficacy of oral organic nitrates.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 367136     DOI: 10.1016/s0002-9149(79)80014-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.

Authors:  S Silber
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  The haemodynamic and anti-ischaemic effects of a single tablet of 80 mg isosorbide dinitrate in slow-release formulation and a review of nitrate tolerance.

Authors:  S Silber; A C Vogler; K H Krause; K Theisen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

3.  Availability of isosorbide dinitrate, diazepam and chlormethiazole, from i.v. delivery systems.

Authors:  P A Cossum; M S Roberts
Journal:  Eur J Clin Pharmacol       Date:  1981-02       Impact factor: 2.953

4.  Kinetics of isosorbide dinitrate and relationships to pharmacological effects.

Authors:  H L Fung; E F McNiff; D Ruggirello; A Darke; U Thadani; J O Parker
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

Review 5.  Short and long-acting oral nitrates for stable angina pectoris.

Authors:  U Thadani; R J Lipicky
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

6.  Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris.

Authors:  M A James; P R Walker; M Papouchado; P R Wilkinson
Journal:  Br Heart J       Date:  1985-06

Review 7.  Glyceryl trinitrate (nitroglycerin) ointment and isosorbide dinitrate: a review of their pharmacological properties and therapeutic use.

Authors:  U Elkayam; W S Aronow
Journal:  Drugs       Date:  1982-03       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.